Jean‐Pierre Lindenmayer

9.2k total citations · 2 hit papers
134 papers, 6.9k citations indexed

About

Jean‐Pierre Lindenmayer is a scholar working on Psychiatry and Mental health, Clinical Psychology and Experimental and Cognitive Psychology. According to data from OpenAlex, Jean‐Pierre Lindenmayer has authored 134 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 109 papers in Psychiatry and Mental health, 32 papers in Clinical Psychology and 31 papers in Experimental and Cognitive Psychology. Recurrent topics in Jean‐Pierre Lindenmayer's work include Schizophrenia research and treatment (99 papers), Bipolar Disorder and Treatment (33 papers) and Mental Health Research Topics (28 papers). Jean‐Pierre Lindenmayer is often cited by papers focused on Schizophrenia research and treatment (99 papers), Bipolar Disorder and Treatment (33 papers) and Mental Health Research Topics (28 papers). Jean‐Pierre Lindenmayer collaborates with scholars based in United States, Canada and Germany. Jean‐Pierre Lindenmayer's co-authors include Stanley R. Kay, Lewis A. Opler, Anzalee Khan, Sandra Grochowski, Mariëlle Eerdekens, Paul H. Lysaker, R.M. Milstein, Joseph L. Goulet, Morris D. Bell and John M. Kane and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and The British Journal of Psychiatry.

In The Last Decade

Jean‐Pierre Lindenmayer

125 papers receiving 6.6k citations

Hit Papers

The Positive and Negative Syndrome Scale (PANSS): Rationa... 1988 2026 2000 2013 1989 1988 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Positive and Negative Syndrome Scale (PANSS): Rationale and Standardisation
    1989 858 citations Stanley R. Kay, Jean‐Pierre Lindenmayer et al. profile →
  2. Reliability and validity of the positive and negative syndrome scale for schizophrenics
    1988 830 citations Stanley R. Kay, Jean‐Pierre Lindenmayer et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean‐Pierre Lindenmayer United States 42 5.2k 1.7k 1.5k 1.1k 1.1k 134 6.9k
Ofer Agid Canada 42 4.0k 0.8× 1.2k 0.8× 1.1k 0.7× 1.1k 0.9× 1.0k 1.0× 135 5.9k
Robin Emsley South Africa 50 5.2k 1.0× 2.4k 1.5× 1.4k 0.9× 853 0.7× 804 0.8× 281 8.5k
Nina R. Schooler United States 55 7.2k 1.4× 2.7k 1.6× 1.9k 1.3× 1.2k 1.1× 787 0.7× 208 9.3k
Robert Goldman United States 36 3.9k 0.8× 1.2k 0.7× 1.0k 0.7× 1.4k 1.2× 548 0.5× 100 5.4k
Miranda Chakos United States 35 6.1k 1.2× 1.7k 1.0× 1.5k 1.0× 1.4k 1.2× 440 0.4× 62 7.7k
Rajiv Tandon United States 50 5.4k 1.1× 1.8k 1.1× 1.5k 1.0× 1.8k 1.6× 958 0.9× 246 8.9k
Joanne B. Severe United States 23 7.5k 1.4× 3.6k 2.2× 1.2k 0.8× 1.2k 1.1× 807 0.8× 39 9.9k
Ruud van Winkel Belgium 48 5.3k 1.0× 2.2k 1.3× 740 0.5× 872 0.8× 946 0.9× 201 9.1k
Larry Alphs United States 36 3.8k 0.7× 1.1k 0.7× 937 0.6× 584 0.5× 693 0.7× 174 5.2k
Dieter Naber Germany 55 6.5k 1.3× 2.4k 1.5× 1.9k 1.3× 1.2k 1.1× 1.3k 1.2× 333 10.4k

Countries citing papers authored by Jean‐Pierre Lindenmayer

Since Specialization
Citations

This map shows the geographic impact of Jean‐Pierre Lindenmayer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Pierre Lindenmayer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Pierre Lindenmayer more than expected).

Fields of papers citing papers by Jean‐Pierre Lindenmayer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Pierre Lindenmayer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Pierre Lindenmayer. The network helps show where Jean‐Pierre Lindenmayer may publish in the future.

Co-authorship network of co-authors of Jean‐Pierre Lindenmayer

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Pierre Lindenmayer. A scholar is included among the top collaborators of Jean‐Pierre Lindenmayer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Pierre Lindenmayer. Jean‐Pierre Lindenmayer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Alphs, Larry, Dong‐Jing Fu, David J. Williamson, et al.. (2022). SIBAT-A Computerized Assessment Tool for Suicide Ideation and Behavior: Development and Psychometric Properties.. PubMed. 19(4-6). 36–47. 2 indexed citations
4.
Lindenmayer, Jean‐Pierre, et al.. (2020). M120. IMPAIRED CLINICAL INSIGHT AS A PREDICTOR OF RELAPSE IN SCHIZOPHRENIA. Schizophrenia Bulletin. 46(Supplement_1). S180–S181.
5.
Khan, Anzalee, et al.. (2020). The psychometric properties of the Self-Evaluation of Negative Symptoms Scale (SNS) in treatment-resistant schizophrenia (TRS). Schizophrenia Research. 224. 159–166. 7 indexed citations
6.
Allen, Michael H., David G. Daniel, Dennis A. Revicki, et al.. (2012). Development and psychometric evaluation of a clinical global impression for schizoaffective disorder scale.. PubMed. 9(1). 15–24. 16 indexed citations
7.
Lindenmayer, Jean‐Pierre, Susan R. McGurk, Anzalee Khan, et al.. (2012). Improving Social Cognition in Schizophrenia: A Pilot Intervention Combining Computerized Social Cognition Training With Cognitive Remediation. Schizophrenia Bulletin. 39(3). 507–517. 111 indexed citations
8.
Turkoz, Ibrahim, Cynthia A. Bossie, Jean‐Pierre Lindenmayer, Nina R. Schooler, & Carla M. Canuso. (2011). Paliperidone ER and oral risperidone in patients with schizophrenia: a comparative database analysis. BMC Psychiatry. 11(1). 21–21. 31 indexed citations
9.
Sedky, Karim, et al.. (2010). Paliperidone Palmitate: Once-Monthly Treatment Option for Schizophrenia. Current psychiatry. 9(3). 48. 7 indexed citations
10.
Canuso, Carla M., Jean‐Pierre Lindenmayer, Colette Kosik‐Gonzalez, et al.. (2010). A Randomized, Double-Blind, Placebo-Controlled Study of 2 Dose Ranges of Paliperidone Extended-Release in the Treatment of Subjects With Schizoaffective Disorder. The Journal of Clinical Psychiatry. 71(5). 587–598. 55 indexed citations
11.
Veach, Jeffrey, et al.. (2010). Assessment of Clinician Awareness of Nonadherence Using a New Structured Rating Scale. Journal of Psychiatric Practice. 16(3). 164–169. 13 indexed citations
12.
Lindenmayer, Jean‐Pierre, et al.. (2006). Improved Long-Term Outcome with Long-Acting Risperidone Treatment of Chronic Schizophrenia with Prior Partial Response. Journal of Psychiatric Practice. 12(1). 55–57. 3 indexed citations
13.
Casey, Daniel E., Dan Haupt, John W. Newcomer, et al.. (2004). Schizophrenia, Metabolic Disorders, and Cardiovascular Disease. The Journal of Clinical Psychiatry. 65. 8–8. 2 indexed citations
14.
Lindenmayer, Jean‐Pierre & Anzalee Khan. (2004). Pharmacological treatment strategies for schizophrenia. Expert Review of Neurotherapeutics. 4(4). 705–723. 15 indexed citations
15.
Volavka, Jan, James L. Kennedy, Xingqun Ni, et al.. (2003). COMT158 polymorphism and hostility. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 127B(1). 28–29. 27 indexed citations
16.
Kane, John M., Mariëlle Eerdekens, Jean‐Pierre Lindenmayer, et al.. (2003). Long-Acting Injectable Risperidone: Efficacy and Safety of the First Long-Acting Atypical Antipsychotic. American Journal of Psychiatry. 160(6). 1125–1132. 379 indexed citations
17.
Lindenmayer, Jean‐Pierre, Anna Marie Nathan, & Robert C. Smith. (2001). Hyperglycemia associated with the use of atypical antipsychotics.. PubMed. 62 Suppl 23. 30–8. 130 indexed citations
18.
Javitt, Daniel C., et al.. (1994). Amelioration of negative symptoms in schizophrenia by glycine. American Journal of Psychiatry. 151(8). 1234–1236. 282 indexed citations
19.
Lindenmayer, Jean‐Pierre & Stanley R. Kay. (1992). New biological vistas on schizophrenia. 14 indexed citations
20.
Kay, Stanley R., et al.. (1989). Ascorbate an adjunctive treatment for schizophrenia. Journal of the American College of Nutrition. 8(5). 425. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ofer Agid Breakdown of academic impact, for papers by Robin Emsley Breakdown of academic impact, for papers by Nina R. Schooler Breakdown of academic impact, for papers by Robert Goldman Breakdown of academic impact, for papers by Miranda Chakos Breakdown of academic impact, for papers by Rajiv Tandon Breakdown of academic impact, for papers by Joanne B. Severe Breakdown of academic impact, for papers by Ruud van Winkel Breakdown of academic impact, for papers by Larry Alphs Breakdown of academic impact, for papers by Dieter Naber
Rankless by CCL
2026